- Home
- ELVN vs REX Comparison
ELVN vs REX Comparison
Compare ELVN & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- REX
- Stock Information
- Founded
- ELVN 2016
- REX 1980
- Country
- ELVN United States
- REX United States
- Employees
- ELVN N/A
- REX N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- REX Major Chemicals
- Sector
- ELVN Health Care
- REX Industrials
- Exchange
- ELVN Nasdaq
- REX Nasdaq
- Market Cap
- ELVN 1.1B
- REX 1.1B
- IPO Year
- ELVN 2020
- REX N/A
- Fundamental
- Price
- ELVN $20.33
- REX $33.62
- Analyst Decision
- ELVN Strong Buy
- REX Strong Buy
- Analyst Count
- ELVN 5
- REX 1
- Target Price
- ELVN $41.20
- REX $25.00
- AVG Volume (30 Days)
- ELVN 573.6K
- REX 160.9K
- Earning Date
- ELVN 11-07-2025
- REX 12-02-2025
- Dividend Yield
- ELVN N/A
- REX N/A
- EPS Growth
- ELVN N/A
- REX N/A
- EPS
- ELVN N/A
- REX 1.49
- Revenue
- ELVN N/A
- REX $650,008,000.00
- Revenue This Year
- ELVN N/A
- REX $3.27
- Revenue Next Year
- ELVN $20.05
- REX $17.11
- P/E Ratio
- ELVN N/A
- REX $22.07
- Revenue Growth
- ELVN N/A
- REX N/A
- 52 Week Low
- ELVN $13.30
- REX $16.73
- 52 Week High
- ELVN $29.38
- REX $33.81
- Technical
- Relative Strength Index (RSI)
- ELVN 49.67
- REX 51.14
- Support Level
- ELVN $16.80
- REX $31.00
- Resistance Level
- ELVN $24.64
- REX $33.97
- Average True Range (ATR)
- ELVN 1.45
- REX 0.90
- MACD
- ELVN -0.23
- REX 0.55
- Stochastic Oscillator
- ELVN 43.11
- REX 79.60
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.